Showing results (541-550 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|February 17, 2023
Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting systemDaniel G Dauner, Rui Zhang, Terrence J Adam, et al.Expert Opinion on Drug Safety|February 24, 2010
Benefit-risk assessment: the use of clinical utility indexDaniele OuelletExpert Opinion on Drug Safety|February 24, 2010
Safety profile of new anticancer drugsLaura Mansi, Antoine Thiery-Vuillemin, Thierry Nguyen, et al.Expert Opinion on Drug Safety|February 24, 2010
Safety Pharmacology Society: 9th Annual MeetingIcilio CaveroExpert Opinion on Drug Safety|December 10, 2009
A review of acitretin for the treatment of psoriasisChai Sue Lee, Kai LiExpert Opinion on Drug Safety|April 14, 2021
Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical productsNasr Eldin Hussein Nasr, Metwaly Gamel Metwaly, Eman Osama Ahmed, et al.Expert Opinion on Drug Safety|April 19, 2021
Malignant syndromes: current advancesMinghua Tao, Jiyuan Li, Xuefeng Wang, et al.Expert Opinion on Drug Safety|June 5, 2014
Safety evaluation of ruxolitinib for treating myelofibrosisSofia Galli, Donal McLornan, Claire HarrisonExpert Opinion on Drug Safety|April 17, 2023
High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS databasePan Ma, Hao Tian, Qiuling Shi, et al.Expert Opinion on Drug Safety|April 20, 2023
The safety of phthalate-containing medications used during pregnancyAmaan Ali, Jan Stener Jørgensen, Ronald F LamontPageof 282